List of Medicines Missing from the Health Insurance Fund of the Federation of Bosnia and Herzegovina

On September 1, 2025, the Health Insurance Fund of the Federation of Bosnia and Herzegovina failed to deliver the following medicines to the University Clinical Center Tuzla (cytostatics and medicines for AIDS, hepatitis, inflammatory bowel diseases, pulmonary hypertension, immunoglobulin, coagulation disorders, immunosuppressants, cystic fibrosis, spinal muscular atrophy, and multiple sclerosis): – Azacitidine – Cytarabine –…

University Clinical Center Tuzla Enhances Diagnostic Capacities with New Equipment

With the support of the Government of Tuzla Canton, the Department of Pathology at the Polyclinic for Laboratory Diagnostics of the University Clinical Center Tuzla (UKC Tuzla) has been equipped with state-of-the-art medical technology. The new equipment includes advanced microscopes for pathology diagnostics, a specialized workstation for microscopic sampling, an automatic slide counter with coverslip…

UKC Tuzla Eye Clinic Introduces Innovative Drug Faricimab into Clinical Practice

The Clinic for Eye Diseases at the University Clinical Center Tuzla (UKC Tuzla) has introduced faricimab, an innovative drug, into routine clinical use. Faricimab represents the latest therapeutic option for treating conditions such as neovascular (wet) age-related macular degeneration and diabetic macular edema. It is the first dual-inhibitory monoclonal antibody that targets two key pathological…

Tuzla Canton Government Invests 1.4 Million KM in Modernization of ENT and Head and Neck Surgery Clinic at UKC Tuzla

The Government of Tuzla Canton has allocated approximately 1.4 million KM over the past year for the purchase of state-of-the-art medical equipment for the Clinic for Ear, Nose and Throat Diseases and Head and Neck Surgery at the University Clinical Center Tuzla (UKC Tuzla). This investment has enabled the procurement of devices that significantly enhance…